Adam Lipworth to Anti-Bacterial Agents
This is a "connection" page, showing publications Adam Lipworth has written about Anti-Bacterial Agents.
Connection Strength
0.329
-
Lipworth AD, Hyle EP, Fishman NO, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Kasbekar N, Lautenbach E. Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol. 2006 Mar; 27(3):279-86.
Score: 0.152
-
Obaitan I, Dwyer R, Lipworth AD, Kupper TS, Camargo CA, Hooper DC, Murphy GF, Pallin DJ. Failure of antibiotics in cellulitis trials: a systematic review and meta-analysis. Am J Emerg Med. 2016 Aug; 34(8):1645-52.
Score: 0.078
-
Milliken D, Roosinovich E, Wilton H, Lipworth AD, Moore D, Morris-Jones S, Marks DJ. Drug fever and DRESS syndrome. Br J Hosp Med (Lond). 2011 Apr; 72(4):224-8.
Score: 0.054
-
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005 Jun 27; 165(12):1375-80.
Score: 0.036
-
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis. 2005 May 01; 40(9):1317-24.
Score: 0.009